Are people with MS hypersensitive to medications due to increased blood brain permeability? Are they at increased risk to develop side effects to meds that don’t typically cross the BBB? What are the implications for medication administration?
How do people with MS under age 60 compare to those over 60 in terms of occurrence and type of co-morbidities, severity, age of onset, and related factors?
What strategies can be implemented to improve education for primary care physicians on multiple sclerosis?
